Showing results (61-70 of 453) with videos related to
Sort By:
Pageof 46
Future Oncology (London, England)|May 28, 2021
Eribulin in brain metastases of breast cancer: outcomes of the EBRAIM prospective observational trialAlessandra Fabi, Irene Terrenato, Antonello Vidiri, et al.Cancer Nursing|June 23, 2018
The Effectiveness of the Sport "Dragon Boat Racing" in Reducing the Risk of Lymphedema Incidence: An Observational StudyLaura Iacorossi, Francesca Gambalunga, Simona Molinaro, et al.Anticancer Research|July 15, 2009
Pseudoprogression and MGMT status in glioblastoma patients: implications in clinical practiceAlessandra Fabi, Michelangelo Russillo, Giulio Metro, et al.Drugs of Today (Barcelona, Spain : 1998)|May 6, 2003
Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumorsSerena Di Cosimo, Gianluigi Ferretti, Paola Papaldo, et al.Journal of Physics. Condensed Matter : an Institute of Physics Journal|March 15, 2011
Short-range lateral interactions and depolarization of Na atoms on Cu surfacesGuido Fratesi, Andrea Pace, Gian Paolo BrivioOrganic Letters|August 11, 2011
Tandem reactions of 1,2,4-oxadiazoles with allylaminesAntonio Palumbo Piccionello, Andrea Pace, Silvestre BuscemiAnticancer Research|November 11, 2006
Bone and lung metastases from intracranial meningiomaAlessandra Fabi, Carmen Nuzzo, Antonello Vidiri, et al.Epilepsy & Behavior : E&B|June 18, 2017
Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control groupMarta Maschio, Alessia Zarabla, Andrea Maialetti, et al.Breast Cancer (Dove Medical Press)|October 21, 2022
Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 TrialRoberta Caputo, Alessandra Fabi, Emanuela Romagnoli, et al.In Vivo (Athens, Greece)|June 25, 2018
Impressive Long-term Response with Pertuzumab and Trastuzumab in HER2-positive Breast Cancer with Brain MetastasisMichelangelo Russillo, Gianluigi Ferretti, Antonello Vidiri, et al.Pageof 46